Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 24, 2022

SELL
$72.5 - $100.68 $152,250 - $211,428
-2,100 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$99.61 - $142.12 $9,961 - $14,212
-100 Reduced 4.55%
2,100 $278,000
Q3 2020

Nov 03, 2020

BUY
$72.92 - $102.01 $160,424 - $224,422
2,200 New
2,200 $224,000
Q3 2019

Oct 15, 2019

SELL
$90.37 - $122.49 $171,703 - $232,731
-1,900 Closed
0 $0
Q2 2019

Jul 12, 2019

BUY
$89.51 - $118.04 $170,069 - $224,276
1,900 New
1,900 $224,000
Q4 2018

Jan 14, 2019

SELL
$56.04 - $82.66 $274,596 - $405,034
-4,900 Closed
0 $0
Q2 2018

Jul 16, 2018

BUY
$37.84 - $69.96 $185,416 - $342,803
4,900 New
4,900 $293,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.92B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Orgel Wealth Management, LLC Portfolio

Follow Orgel Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orgel Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orgel Wealth Management, LLC with notifications on news.